Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07574177
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular HealthUniversity of South AlabamaNot Yet RecruitingNot Applicable
NCT07574177Not Yet Recruiting
Not Applicable
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiova...University of South Alaba...
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's DiseaseIran University of Medical SciencesRecruitingPhase 1
NCT07572071Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Park...Iran University of Medica...
NCT07573618
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration Versus Standard AnticoagulationWeiwei WuNot Yet RecruitingNot Applicable
NCT07573618Not Yet Recruiting
Not Applicable
Acute or Subacute Iliofemoral Vein Thrombosis: Aspiration for Flow Restoration V...Weiwei Wu
NCT07572175
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart AssociationNot Yet RecruitingPhase 2
NCT07572175Not Yet Recruiting
Phase 2
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart Associatio...
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07573761
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone FormationIstanbul Saglik Bilimleri UniversityEnrolling By Invitation
NCT07573761Enrolling By Invitation
—
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth...Istanbul Saglik Bilimleri...
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573800
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07573800Not Yet Recruiting
Not Applicable
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International Univ...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07574190
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South DakotaNot Yet RecruitingNot Applicable
NCT07574190Not Yet Recruiting
Not Applicable
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South Dakot...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back PainIstinye UniversityCompletedNot Applicable
NCT07573254Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07572357
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07572357Not Yet Recruiting
Not Applicable
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech Consu...
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting2 (10%)
Enrolling by invitation2 (10%)
Completed1 (5%)
not_applicable10 (50%)
Phase 14 (20%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 41 (5%)